Echopoint Medical secures £500k for cardiovascular device development

Cardiovascular device developer Echopoint Medical Ltd has secured an estimated £500k in new funding, according to filings dated 5 May 2026. The London based company, which was incorporated on 9 November 2018, is a spin out from University College London.

The company develops and commercialises the iKOr microcatheter system. This technology is designed for use in cardiology catheter labs to help clinicians diagnose complex heart conditions and improve treatment for patients with diseases such as angina. Echopoint Medical uses optical sensors and advanced algorithms to provide sensing and imaging capabilities during minimally invasive procedures.

This latest allotment, dated 25 March 2026, follows a £1.4m seed round completed in February 2026. That previous round placed the company at a valuation of £12.5m. The company has a history of frequent capital injections, including three separate allotments in 2025 totaling approximately £236k. In February 2024, the firm raised two tranches of funding worth £601k and £4.3m. Earlier funding includes a £1m round in April 2019 and a £700k round in July 2019.

Echopoint Medical currently lists six employees in its latest accounts, while its LinkedIn profile indicates a headcount of 17. The team includes engineers and clinicians focused on optical ultrasound and data analytics for interventional cardiology. The company is headquartered in London and focuses on the manufacture of medical instruments and supplies.